The discrepancies between double versus single knock-out models may be attributed to RIDD counteractivation in XBP1-deficient tumor cDC1s (Figures 2D, E), which is a phenotype reported in XBP1-knock-out cDC1s in steady state (21, 22). Here, XBP1 is linked to neoplasm.